Transitions from injecting to non-injecting drug use: potential protection against HCV infection.
about
Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey.Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventionsIncidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug UsersPerceived health and alcohol use in individuals with HIV and Hepatitis C who use drugs.From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.Perceived risk for severe outcomes and drinking status among drug users with HIV and Hepatitis C Virus (HCV).
P2860
Q34260638-DA8A4A56-1FD9-4786-9AEF-4C2AD98B83F0Q34545139-FB4D980C-FD9E-43E7-AD53-5122CD7B9741Q35690302-D6E1D4CD-BEC0-4B58-BC5C-159CA81AB709Q35998417-C4F6634E-AE4F-4270-A42B-C7CE510C0328Q36669743-23687241-9677-431D-989C-599AC5D11BCAQ37305713-019DB59E-C93A-4753-A2A9-79DD54487ECDQ40273876-95FCB9C0-3D69-4701-A162-D393E843C492Q40487477-8C8E424E-064D-4DDE-B3A8-43D57F56CECFQ40611489-378C0AA1-B84D-4822-A898-623368617E74
P2860
Transitions from injecting to non-injecting drug use: potential protection against HCV infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transitions from injecting to ...... tection against HCV infection.
@en
Transitions from injecting to ...... tection against HCV infection.
@nl
type
label
Transitions from injecting to ...... tection against HCV infection.
@en
Transitions from injecting to ...... tection against HCV infection.
@nl
prefLabel
Transitions from injecting to ...... tection against HCV infection.
@en
Transitions from injecting to ...... tection against HCV infection.
@nl
P2093
P2860
P1476
Transitions from injecting to ...... tection against HCV infection.
@en
P2093
Courtney McKnight
David C Perlman
Don C Des Jarlais
Hannah L F Cooper
Jonathan Feelemyer
Kamyar Arasteh
P2860
P304
P356
10.1016/J.JSAT.2013.09.004
P50
P577
2013-10-23T00:00:00Z